Skip to content
Business Times – Lifestyle
Author:
Life Biosciences
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
June 9, 2026
Life Biosciences Secures $80 Million Series D Financing
April 8, 2026